Clinical Trial Update: A Study of Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for relapsing-remitting multiple sclerosis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: Eli Lilly and Company | Conditions: Relapsing-Remitting Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2018-11-15